1,041
Views
29
CrossRef citations to date
0
Altmetric
Systemic disease and Oral bacteria

Rheumatoid arthritis and the role of oral bacteria

, , , &
Article: 5784 | Published online: 21 Dec 2010

References

  • Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996; 1: 1–36.
  • Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol. 2003; 74: 103–10.
  • Silman AJ, MacGregor AJ, Thompson W, Holligan S, Carthy D, Farhan A, et al.. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol. 1993; 32: 903–7.
  • Bellamy N, Duffy D, Martin N, Mathews J. Rheumatoid arthritis in twins: a study of aetiopathogenesis based on the Australian twin registry. Ann Rheum Dis. 1992; 51: 588–93.
  • Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005; 4: 130–6.
  • Albani S, Carson DA, Roudier J. Genetic and environmental factors in the immune pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am. 1992; 18: 729–40.
  • Deng GM, Tarkowski A. The role of bacterial DNA in septic arthritis. Int J Mol Med. 2000; 6: 29–33.
  • Deng GM, Tarkowski A. The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum. 2000; 43: 356–64.
  • Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol. 2006; 2: 425–33.
  • Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL. Amplification of plasmid and chromosome chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum. 1995; 38: 1005–13.
  • Branigan PJ, Gerard HC, Hudson AP, Schumacher HR Jr, Pando J. Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum. 1996; 39: 1740–6.
  • Hyrich KL, Inman RD. Infectious agents in chronic rheumatic diseases. Curr Opin Rheumatol. 2001; 13: 300–4.
  • Cuchacovich R, Japa S, Huang WQ, Calvo A, Vega L, Vargas RB, et al.. Detection of bacterial DNA in Latin America patients with reactive arthritis by polymerase chain reaction and sequencing analysis. J Rheumatol. 2002; 29: 1426–9.
  • Zhang X, Pacheco-Tena C, Inman R. Microbe hunting in the joints. Arthritis Rheum. 2003; 49: 479–82.
  • Cox CJ, Kempsell KE, Hill Gaston JS. Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA. Arthritis Res Ther. 2003; 5: R1–R8.
  • Woolley DE, Tetlow LC. Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis. Ann Rheum Dis. 1997; 56: 151–61.
  • Haynes DR, Crotti TN, Loric M, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology. 2001; 40: 623–30.
  • Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junctions in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol. 1992; 31: 653–61.
  • Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Reumatol. 1999; 26: 1650–3.
  • Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hyphothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004; 28: 311–8.
  • Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. J Med Microbiol. 2000; 49: 305–11.
  • Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol. 2005; 76: 2066–74.
  • Carty SM, Snowden N, Silman AJ. Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?. Ann Rheum Dis. 2003; 30: 425–9.
  • Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol. 2000; 27: 267–72.
  • Pischon N, Pischon T, Kröger J, Gülmez E, Kleber BM, Bernimoulin JP, et al.. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008; 79: 979–86.
  • Carty SM, Snowden N, Silman AJ. Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?. Ann Rheum Dis. 2004; 63: ii46–ii49.
  • Schett G, Redlich K, Xu Q, Bizan P, Groger M, Tohidast-Akrad M, et al.. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest. 1998; 102: 301–11.
  • Yoshida A, Nakano Y, Yamashita T, Oho T, Ito H, Kondo M, et al.. Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res. 2001; 80: 346–50.
  • Weyand CM, Goronzy JJ. Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res. 2000; 2: 203–4.
  • Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis. 2006; 65: 905–9.
  • Trombone AP, Claudino M, Colavite P, de Assis GF, Avila-Campos MJ, Silva JS, et al.. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun. 2010; 11: 479–89.
  • Arend WP, Dayer JM. Cytokines and cytokine or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990; 33: 305–15.
  • Tolo K, Jorkjend L. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis. J Clin Periodontol. 1990; 17: 288–91.
  • Yusof Z, Porter SR, Greenman J, Scully C. Levels of serum IgG against Porphyromonas gingivalis in patients with rapidly progressive periodontitis, rheumatoid arthritis and adult periodontitis. J Nihon Univ Sch Dent. 1995; 37: 197–200.
  • Wilbrink B, van de Heijden IM, Schouls LM, van Embden JDA, Hazez JMW, Breedveld FC, et al.. Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum. 1998; 41: 535–43.
  • Braun J, Tuszewski M, Eggens U, Mertz A, Schauer-Petrowskaja C, Doring E, et al.. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol. 1997; 24: 1092–100.
  • Gerard HC, Wang Z, Feng Wang G, El-Gabalawy H, Goldbach-Mansky R, Li Y, et al.. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum. 2001; 44: 1689–97.
  • Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. Med Gen Med. 2005; 7: 2.
  • Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, et al.. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol. 2006; 24: 656–63.
  • Mikuls TR, Ayne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, et al.. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol. 2009; 9: 38–42.
  • Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, Rizo-Rodriguez JC, Little JW, Loyola-Rodriguez JP. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol. 2009; 36: 1004–10.
  • Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol. 2005; 32: 708–13.
  • de Pablo P, Chapple ILC, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol. 2009; 5: 218–24.
  • Pierce DL, Nishiyama S, Liang S, Wang M, Triantafilou M, Triantafilou K, et al.. Host adhesive activities and virulence of novel fimbrial proteins of Porphyromonas gingivalis. Infect Immun. 2009; 77: 3294–301.
  • Moen K, Brun JG, Madland TM, Tynning T, Jonsson R. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diag Lab Immnunol. 2003; 10: 1043–50.
  • Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, et al.. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010; 233: 34–54.
  • Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, et al.. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010; 62: 2662–72.
  • Liao F, Li Z, Wang Y, Shi B, Ging Z, Cheng X. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses. 2009; 72: 732–5.
  • Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, et al.. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol. 2010; 37: 1105–12.
  • Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, et al.. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008; 58: 3009–19.
  • Bartold PM, Marino V, Cantley M, Haynes DR. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010; 37: 405–11.
  • Pischon N, Röhner E, Hocke A, N'Guessan P, Müller HC, Matziolis G, et al.. Effects of Porphyromonas gingivalis on cell cycle progression and apoptosis of primary human chondrocytes. Ann Rheum Dis. 2009; 68: 1902–7.
  • Ghosh A, Park JY, Fenno C, Kapila YL. Porphyromonas gingivalis, gamma interferon, and a proapoptotic fibronectin matrix form a synergistic trio that induces c-Jun N-terminal kinase 1-mediated nitric oxide generation and cell death. Infect Immun. 2008; 76: 5514–23.
  • Yu JJ, Ruddy MJ, Conti HR, Boonanantanasarn K, Gaffen SL. The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect and Immun. 2008; 76: 4206–13.
  • Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci. 2008; 13: 170–7.
  • Jacobson JJ, Patel B, Asher G, Woolliscroft JO, Schaberg D. Oral staphylococcus in older subjects with rheumatoid arthritis. J Am Geriatr Soc. 1997; 45: 590–3.
  • Jackson MS, Bagg J, Gupta MN, Sturrock RD. Oral carriage of staphylococci in patients with rheumatoid arthritis. Rheumatol. 1999; 38: 572–5.
  • Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, et al.. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factors inhibitors. J Periodontol. 2009; 80: 535–40.
  • Ribeiro J, Leao A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol. 2005; 32: 412–6.
  • Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol. 2007; 13: 134–7.
  • Modi DK, Chopra VS, Bhau U. Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies. Indian J Den Res. 2009; 20: 86–90.
  • Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Siesiewicz E, Chwiecko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol. 2007; 34: 890–2.
  • Stone M, Fortin PR, Pacheco-Tena C, Inman RD. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Meta analysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol. 2003; 30: 2112–22.
  • Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al.. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006; 38: 306–21.
  • Salvi GE, Williams RC, Offenbacher S. Nonsteroidal anti-inflammatory drugs as adjuncts in the management of periodontal diseases and peri-implantitis. Curr Opin Periodontol. 1997; 4: 51–8.
  • Pillinger MH, Capodici C, Rosenthal P, Kheterpal N, Hanft S, Philips MR, et al.. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA. 1998; 95: 14540–5.
  • Lavagno L, Gunella G, Bardelli C, Spina S, Fresu LG, Viano I, et al.. Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription of factor NF-kappa B and implication for rheumatoid arthritis therapy. Eur J Pharmacol. 2004; 501: 199–208.
  • Albandar JM, DeNardin AM, Adesanya MR, Diehl SR, Winn DM. Association between serum antibody levels to periodontal pathogens and early-onset periodontitis. J Periodontol. 2001; 72: 1463–9.
  • Ebersole JL, Cappelli D, Mathys EC, Steffen MJ, Singer RE, Montgomery M, et al.. Periodontitis in humans and non-humans primates: oral-systemic linkage inducing acute phase proteins. Ann Periodontol. 2002; 7: 102–11.
  • Bassetti S, Wasmer S, Hasler P, Vogt T, Nogarth D, Frei R, et al.. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol. 2005; 32: 2125–9.